title: Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction.
abstract: Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are leading causes of morbidity and mortality in the elderly. Both diseases are characterized by amyloid deposition in target tissues: aggregation of amylin in T2DM is associated with loss of insulin-secreting beta-cells, while amyloid beta (A beta) aggregation in AD brain is associated with neuronal loss. Here, we used quantitative iTRAQ proteomics as a discovery tool to show that both A beta and human amylin (HA) deregulate identical proteins, a quarter of which are mitochondrial, supporting the notion that mitochondrial dysfunction is a common target in these two amyloidoses. A functional validation revealed that mitochondrial complex IV activity was significantly reduced after treatment with either HA or A beta, as was mitochondrial respiration. In comparison, complex I activity was reduced only after treatment with HA. A beta and HA, but not the non-amyloidogenic rat amylin, induced significant increases in the generation of ROS. Co-incubation of HA and A beta did not produce an augmented effect in ROS production, again suggesting common toxicity mechanisms. In conclusion, our data suggest that A beta and HA both exert toxicity, at least in part, via mitochondrial dysfunction, thus restoring their function may be beneficial for both AD and T2DM.
authors.affiliation: Alzheimer's & Parkinson's Disease Laboratory, Brain & Mind Research Institute, University of Sydney, Camperdown, Australia.
authors.forename: Yun-An
authors.initials: YA
authors.lastname: Lim
authors.forename: Virginie
authors.initials: V
authors.lastname: Rhein
authors.forename: Ginette
authors.initials: G
authors.lastname: Baysang
authors.forename: Fides
authors.initials: F
authors.lastname: Meier
authors.forename: Anne
authors.initials: A
authors.lastname: Poljak
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Raftery
authors.forename: Michael
authors.initials: M
authors.lastname: Guilhaus
authors.forename: Lars M
authors.initials: LM
authors.lastname: Ittner
authors.forename: Anne
authors.initials: A
authors.lastname: Eckert
authors.forename: Jürgen
authors.initials: J
authors.lastname: Götz
mesh_terms: D000682:Amyloid / Q000378:metabolism*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D045744:Cell Line, Tumor; D006801:Humans; D058228:Islet Amyloid Polypeptide; D008928:Mitochondria / Q000378:metabolism*; D010101:Oxygen Consumption; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000682:Amyloid; D016229:Amyloid beta-Peptides; D058228:Islet Amyloid Polypeptide; D017382:Reactive Oxygen Species